Skip to main content

Table 3 Frequencies of KIR-HLA combinations among individuals with acute ischemic stroke and in subjects without stroke

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

HLA and KIR interaction

Subjects with acute ischemic stroke

Subjects without acute ischemic stroke

p

2DL2-HLA-C1 (n/%)

25 (21.55)

27 (40.9)

0.007

2DL3-HLA-C1 (n/%)

38 (32.75)

22 (33.3)

0.93

2DS2-HLA-C1 (n/%)

37 (31.89)

23 (34.48)

0.94

2DS2-HLA-C2 (n/%)

29 (25.0)

4 (6.06)

0.001

2DL2-HLA-C2 (n/%)

26 (22.41)

11 (16.67)

0.34

2DS1-HLA-C2 (n/%)

15 (12.93)

5 (7.57)

0.42

2DL1-HLA-C1 (n/%)

16 (13.79)

7 (10.6)

0.52

2DL1-HLA-C2 (n/%)

17 (14.65)

13 (13.79)

0.41

  1. KIR killer cell immunoglobulin-like receptor, HLA human leukocyte antigen